We describe an HLA transgenic mouse that acquires fully human TCR mimic antibodies through a proprietary immunization procedure.
Beacon on-chips screening and high-throughput binding validation accelerate antibody discovery.
Diversified antibody sequences ensure the screening of antibodies with high specificity and high affinity.